FDA Inspection 1199996 — Titan Implants, Inc

Titan Implants, Inc — FEI 3003024548

The FDA completed an inspection of Titan Implants, Inc on Mar 16, 2023 in Bergenfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 10 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 16, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Bergenfield, NJ (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
315921 CFR 820.184DHR content
322621 CFR 820.70(g)(1)Maintenance schedule, Lack of or inadequate schedule
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
369621 CFR 820.100(b)Documentation
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.